A phase 2 randomized, double-blind, placebo-controlled study of oral allopregnanolone (LYT-300) for the treatment of premutation carriers with fxtas…

Ended Project Grant Awarded Last action

Award ID
HT94252310598
Recipient
Awarding agency
Obligated
$524,924

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02210, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Changes the principal investigator PI from DR. Janet schnee to DR. Michael chen. Removes payment for awards that require human use approval. A phase 2… $0
Original award $524,924

Quick answers

Who received award HT94252310598?

HT94252310598 was awarded to Puretech Health LLC by Defense Health Agency (Department of Defense) on August 1, 2023.

How much is award HT94252310598 worth?

$524,924 has been obligated on HT94252310598.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login